Phenylephrine Hydrochloride Injectable Solution
cGMP deviations.
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
cGMP deviations
Cause type: cGMP deviation
Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.
Sinus Relief (acetaminophen 325mg, Guaifenesin 200mg, phenylephrine HCl 5mg), 2-tablet packets, Manufactured for Select Corporation, Carrollton, TX 75007
Drug: Phenylephrine Category: Pain Relief & OTC Medication
Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
cGMP deviations.
Incorrect Product Formulation
CGMP Deviations
Sub-Potent Drug: Subpotent assay results during stability testing.
Lack of Assurance of Sterility: Leaking/damaged syringes.
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.